Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-15 Sale |
2025-04-17 4:11 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
1,700 | $11.92 | $20,264 | 3,077,216 (Indirect) |
View |
| 2025-04-14 Sale |
2025-04-15 10:20 am |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
15,400 | $11.67 | $179,718 | 3,078,916 (Indirect) |
View |
| 2025-04-10 Sale |
2025-04-14 12:33 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
30,156 | $11.14 | $335,938 | 3,094,316 (Indirect) |
View |
| 2025-04-03 Sale |
2025-04-07 12:30 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
17,210 | $11.97 | $205,932 | 3,124,472 (Indirect) |
View |
| 2025-04-01 Sale |
2025-04-03 5:22 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
46,723 | $12.34 | $576,754 | 3,141,682 (Indirect) |
View |
| 2025-03-31 Sale |
2025-04-01 4:21 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
48,623 | $12.58 | $611,677 | 3,188,405 (Indirect) |
View |
| 2025-03-27 Sale |
2025-03-31 12:07 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
36,524 | $13 | $474,961 | 3,237,028 (Indirect) |
View |
| 2025-03-24 Sale |
2025-03-25 11:47 am |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
2,329 | $13.21 | $30,766 | 3,273,552 (Indirect) |
View |
| 2025-02-26 Sale |
2025-02-27 10:09 am |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
200 | $13.62 | $2,724 | 3,275,881 (Indirect) |
View |
| 2025-02-13 Sale |
2025-02-18 1:09 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
100 | $13.88 | $1,388 | 3,276,081 (Indirect) |
View |
| 2025-02-12 Sale |
2025-02-13 7:45 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
36,536 | $13.75 | $502,370 | 3,276,181 (Indirect) |
View |
| 2025-02-10 Sale |
2025-02-12 1:00 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
62,743 | $13.89 | $871,709 | 3,312,717 (Indirect) |
View |
| 2025-02-03 Sale |
2025-02-05 10:39 am |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
5,911 | $14.04 | $83,013 | 3,375,460 (Indirect) |
View |
| 2025-01-30 Sale |
2025-02-03 3:30 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
36,978 | $14.21 | $525,274 | 3,381,371 (Indirect) |
View |
| 2025-01-29 Sale |
2025-01-30 10:57 am |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
11,674 | $14.12 | $164,837 | 3,418,349 (Indirect) |
View |
| 2024-08-23 Purchase |
2024-08-27 2:46 pm |
abrdn Life Sciences Investors | HQL | Maher Bill Director |
650 | $15.37 | $9,991 | 1,715 (Indirect) |
View |
| 2024-07-16 Purchase |
2024-07-18 2:56 pm |
abrdn Life Sciences Investors | HQL | DiMartino Rose Director |
1,000 | $15.53 | $15,530 | 1,000 (Direct) |
View |
| 2024-06-26 Purchase |
2024-06-27 11:22 am |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
100 | $14.07 | $1,407 | 3,429,991 (Indirect) |
View |
| 2024-06-24 Purchase |
2024-06-25 5:36 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
13,812 | $14.08 | $194,473 | 3,429,891 (Indirect) |
View |
| 2024-06-12 Purchase |
2024-06-14 1:59 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
10,867 | $13.83 | $150,326 | 3,416,079 (Indirect) |
View |
| 2024-06-10 Purchase |
2024-06-11 5:03 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
11,743 | $13.72 | $161,098 | 3,405,212 (Indirect) |
View |
| 2024-06-06 Purchase |
2024-06-10 08:45 am |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
13,361 | $13.78 | $184,081 | 3,393,469 (Indirect) |
View |
| 2024-06-04 Purchase |
2024-06-05 5:09 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
59,440 | $13.61 | $809,222 | 3,380,108 (Indirect) |
View |
| 2024-05-31 Purchase |
2024-06-03 5:11 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
21,369 | $13.29 | $283,994 | 3,320,668 (Indirect) |
View |
| 2024-05-28 Purchase |
2024-05-31 3:08 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
47,416 | $13.14 | $623,176 | 3,299,299 (Indirect) |
View |
| 2024-05-23 Purchase |
2024-05-23 7:41 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
1,303 | $13.5 | $17,591 | 3,251,883 (Indirect) |
View |
| 2024-05-15 Purchase |
2024-05-17 12:34 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
34,755 | $14.19 | $493,173 | 3,250,580 (Indirect) |
View |
| 2024-05-10 Purchase |
2024-05-14 1:50 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
57,862 | $13.86 | $801,967 | 3,215,825 (Indirect) |
View |
| 2024-05-08 Purchase |
2024-05-10 10:31 am |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
28,359 | $13.76 | $390,256 | 3,157,963 (Indirect) |
View |
| 2024-05-06 Purchase |
2024-05-07 5:07 pm |
abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner |
60,874 | $13.74 | $836,126 | 3,129,604 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-06-18 3:18 pm |
N/A N/A |
abrdn Life Sciences Investors | HQL | Nichols Rebecca Suzanne Director of Adviser Director |
0 | $0 | 0 (Direct) |
View |